From: The emerging functions and clinical implications of circRNAs in acute myeloid leukaemia
CircRNAs | Host gene | Level | Mechanism | Downstream molecule/signaling | Biological Function | References |
---|---|---|---|---|---|---|
CircMYBL2 (Hsa_circ_0006332) | MYBL2 | ↑ in FLT3-ITD+ AML | Bind to PTBP1 | FLT3, STAT5, c-MYC, MCL1, p27/Kip1 | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Differentiation (−); Drug resistance (+) | [46] |
Hsa_circ_0004136 (Circ_KCNQ5) | KCNQ5 | ↑ in AML; ↑ in the exosomes derived from AML serum and cell lines | Sponge miR-142; Sponge miR-622 and derepress RAB10; Sponge miR-570-3p and derepress TSPAN3 | PCNA | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Migration and invasion (+) | |
Hsa_circ_0009910 | MFN2 | ↑ in AML; ↑ in the exosomes derived from AML cell lines | Sponge miR-20a-5p; Sponge miR-5195-3p and derepress GRB10 | Bax, Bcl-2 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | |
Circ-ANXA2 (Hsa_circ_0035559) | ANXA2 | ↑ in AML | Target miR-23a-5p and miR-503-3p | NR | Proliferation (+); Apoptosis (−); Drug resistance (+) | [74] |
CircTASP1 (Hsa_circ_406083; Hsa_circ_0007340) | TASP1 | ↑ in AML | Sponge miR-515-5p and upregulate HMGA2 | Bax, Cleaved caspase-3, Bcl-2 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [75] |
CircRNF220 (Hsa_circ_0012152) | RNF220 | ↑ in AML; ↑ in AML serum | Through miR-30a/MYSM1, miR-30a/IER2; miR-625-5p/SOX12; miR-330-5p/SOX4 axis | CyclinD1, Cleaved caspase-3; NF-κB, mTOR, FoxO signaling | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Differentiation (−); Migration and invasion (+) | |
CircZBTB46 (Hsa_circ_103104) | ZBTB46 | ↑ in AML | Sponge miR-671-5p and derepress SCD | PI3 K-AKT, MAPK, mTOR signaling | Proliferation (+); Cell cycle progress (+); Ferroptosis (−) | [77] |
CircBCL11B | BCL11B | ↑ in AML | NR | NR | Proliferation (+); Apoptosis (−) | [84] |
Hsa_circ_0079480 | ISPD | ↑ in AML | Sponge miR-654-3p and derepress HDGF | NR | Proliferation (+); Apoptosis (−) | [119] |
F-circPR | PML-RARα | de novo in AML | NR | AKT signaling | Proliferation (+); Apoptosis (−); Drug resistance (+) | [120] |
F-circM9 | MLL-AF9 | de novo in AML | NR | MAPK, AKT signaling | Proliferation (+); Apoptosis (−); Drug resistance (+) | [121] |
Circ-PTK2 (Hsa_circ_104700; Hsa_circ_0005273) | PTK2 | ↑ in AML | Sponge miR-330-5p and upregulate FOXM1 | CyclinD1, Bcl-2, Bax | Proliferation (+); Apoptosis (−) | [122] |
Circ_POLA2 | POLA2 | ↑ in AML | Target mature miR-34a and upregulate PD-L1 | CDK4, CDK6 | Proliferation (+); Cell cycle progress (+) | [123] |
Circ_DLEU2 (Hsa_circ_0000488) | DLEU2 | ↑ in AML | Sponge miR-582-5p and upregulate COX2; Sponge miR-496 and upregulate PRKACB | Ki67, Bcl-2, Bax | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [124] |
Circ_0094100 | NR | ↑ in AML | Sponge miR-217 and derepress ATP1B1 | PCNA, CyclinD1, Bcl-2 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [125] |
CircNFIX | NFIX | ↑ in AML | Sponge miR-876-3p and derepress TRIM31 | CyclinD1, Bcl-2, Cleaved caspase-3 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [126] |
Hsa_circ_0000370 | FLI-1 | ↑ inAML; ↑ in FLT3-ITD+ AML | Sponge miR-1299 and upregulate S100 A7 A | NR | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [127] |
Circ_0104700 | HOMER2 | ↑ in AML | Sponge miR-665 and derepress MCM2 | JAK/STAT signaling | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [128] |
Hsa_circ_0044907 | RPS6 KB1 | ↑ in AML | Sponge miR-186-5p and derepress KIT | PCNA, CyclinD1, Cleaved caspase-3 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [129] |
Hsa_circ_0002483 | PTK2 | ↑ in AML | Sponge miR-758-3p and derepress MYC | Cleaved caspase-3, caspase-3, Bax, Bcl-2 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [130] |
Hsa_circ_ 0005774 | CDK1 | ↑ in AML | Sponge miR-192-5p and upregulate ULK1 | PCNA, CyclinD1, Bcl-2 | Proliferation (+); Apoptosis (−); Cell cycle progress (+) | [131] |
CircSPI1 | SPI1 | ↑ in AML | Sponge miR-1307-3p, miR-382-5p, miR-767-5p; Interact with eIF4 AIII | PU.1, p-ERK1/2, Bcl-2, CDK6; Ras, PI3 K/AKT, p53, JAK-STAT, FoxO signaling | Proliferation (+); Apoptosis (−); Differentiation (−) | [132] |
CircSH3BGRL3 | SH3BGRL3 | ↑ in AML | Sponge miR-375-3p and derepress YAP1 | NR | Proliferation (+); Cell cycle progress (+); Differentiation (−); Drug resistance (+) | [133] |
CircRNF13 (Hsa_circ_0001346) | RNF13 | ↑ in AML | Sponge miR-1224-5p | c-MYC, caspase-3/7, Tenascin-C | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Migration and invasion (+) | [136] |
CircRAD18 | RAD18 | ↑ in AML | Sponge miR-206 and derepress PRKACB | Bax, Bcl-2, Cleaved caspase-3 | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Migration and invasion (+) | [137] |
CircPLXNB2 (Hsa_circ_0001257) | PLXNB2 | ↑ in AML | Sponge miR-654-3p and derepress CCND1 | PLXNB2, CyclinD1, Bax, PCNA, Bcl-2 | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Migration and invasion (+) | |
Hsa_circ_0013880 | TXNIP | ↑ in AML | Target USP32/Rap1b axis | CyclinD1, Cleaved caspase-3/9, Cleaved-PARP, CDK4, p21 | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Migration and invasion (+) | [142] |
Circ-SFMBT2 (Hsa_circ_0017639) | SFMBT2 | ↑ in AML; ↑ in AML serum | Sponge miR-582-3p and upregulate ZBTB20 | CyclinD1, MMP9, Bax | Proliferation (+); Apoptosis (−); Migration and invasion (+) | [143] |
Hsa_circ_0003602 (Circ-SMARCC1) | SMARCC1 | ↑ in AML | Sponge miR-502-5p and upregulate IGF1R | NR | Proliferation (+); Apoptosis (−); Migration and invasion (+) | [144] |
Circ_0058058 | NR | ↑ in AML | Sponge miR-4319 and upregulate EIF5 A2 | CyclinD1, Bcl-2, Cleaved caspase-3 | Proliferation (+); Apoptosis (−); Migration and invasion (+) | [145] |
CircPVT1 | PVT1 | ↑ in AML | Stabilize c-Myc protein | CXCR4 | Proliferation (+); Apoptosis (−); Migration and invasion (+) | [146] |
CircNPM1 (Circ_0075001) | NPM1 | ↑ in AML; ↑ in AML serum | Sponge miR-345-5p and derepress FZD5 | NR | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Migration and invasion (+); Drug resistance (+) | [147] |
Hsa_circ_0035381 | PIGB | ↑ in AML | Sponge miR-582-3p and derepress YWHAZ | LC3-II/I, Beclin1 | Proliferation (+); Apoptosis (−); Cell cycle progress (+); Autophagy (+); Oxidative stress (−) | [149] |
Circ_001264 | ST6GALNAC3 | ↑ in AML; ↑ in AML cell-derived exosomes | Sponge miR-502-5p and derepress RAF1 | p38-STAT3 | Proliferation (+); Apoptosis (−); M2 polarization of macrophages (+) | [150] |
Hsa_circ_0121582 | GSK3β | ↓ in AML | Sponge miR-224 and derepress GSK3β; Interact with TET1 | Wnt/β-catenin signaling | Proliferation (−); Cell cycle progress (−) | [151] |
Hsa_circ_0001947 | AFF2 | ↓ in AML | Sponge miR-329-5p and upregulate CREBRF | NR | Proliferation (−); Apoptosis (+) | [152] |
CircCRKL | CRKL | ↓ in AML | Through miR-196a-5p/miR-196b-5p/p27 axis | NR | Proliferation (−); Cell cycle progress (−) | [153] |
Circ_0040823 | BANP | ↓ in AML; ↓ in AML serum | Sponge miR-516b and derepress PTEN | CyclinD1, CyclinE1, Bcl-2, Bax, Cleaved caspase-3 | Proliferation (−); Apoptosis (+); Cell cycle progress (−) | [154] |
Circ_0004277 | WDR37 | ↓ in AML | Sponge miR-134-5p and derepress SSBP2 | NR | Proliferation (−); Migration and invasion (−) | [155] |
Hsa_circ_0001187 | DOPEY2 | ↓ in AML | Sponge miR-499a-5p and upregulate RNF113 A | METTL3, MDM2, p53, p21 | Proliferation (−); Apoptosis (+); Differentiation (+) | [156] |
CircKDM4 C | KDM4 C | ↓ in AML | Sponge hsa-let-7b-5p and upregulate p53 | ACSL4, PTGS2, GPX4, FTH1 | Proliferation (−); Migration and invasion (−); Ferroptosis (+) | [157] |
Circ-HIPK2 | HIPK2 | ↓ in ATRA-treated NB4 cells | Sponge miR-124-3p | NR | ATRA-induced differentiation (+) | [79] |
Hsa_circ_0003420 | NR | ↓ in non-M3 AML stem cells | Target IGF2BP1 | Cleaved caspase-3, Bax, Bcl-2, HOXB4, MYB, ALDH1 A1 | Stemness (−) | [165] |
CircPAN3 | PAN3 | ↑ in ADM-resistant AML cells | Through the regulation of autophagy; miR-153-5p/miR-183-5p-XIAP axis | LC3-II/I, Beclin1, p62, Cleaved caspase-3/9; AMPK/mTOR signaling | Autophagy (+); Drug resistance (+) | |
CircEHBP1 | EHBP1 | ↑ in AML; ↑ in ADR-resistant AML cells | Suppress miR-129 maturation | NR | Drug resistance (+) | [167] |